Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pera Labs
AddedFeb 16, 2024
UpdatedJun 18, 2026
Pera Labs

Pera Labs

Seed

Pera Labs: AI-powered fertility solutions and digiceutical provider.

HQ
Philadelphia, PA, US
Founded
2019
Overview
Compare
Fundraising
Employees
News
Website

Founded with a mission to revolutionize fertility care, Pera Labs offers AI-powered fertility solutions and digiceuticals. The company focuses on providing comprehensive fertility assessments and treatments through innovative technologies. Their flagship product, the Sperman® System, is designed to offer reliable and accessible fertility testing. Pera Labs aims to make fertility care less daunting and more accessible, catering to individuals and couples seeking reproductive health services.

Pera Labs has garnered attention for its cutting-edge approach to fertility, attracting notable investors and experts in the field of reproductive health. The company’s achievements include the successful development and deployment of their AI-driven Sperman® System, which has been well-received in the market for its accuracy and user-friendliness. By integrating advanced technology into fertility care, Pera Labs has made a significant impact on the industry, providing hope and solutions to many facing fertility challenges.

Pera Labs - Similar Companies

Hera Fertility logo

Hera Fertility

herafertility.co

Pregmune logo

Pregmune

pregmune.com

Lilia logo

Lilia

hellolilia.com

Proov logo

Proov

proovtest.com

Univfy logo

Univfy

univfy.com

MedAnswers logo

MedAnswers

Life Whisperer logo

Life Whisperer

lifewhisperer.com

OVATEMP logo

OVATEMP

Legacy logo

Legacy

givelegacy.com

Illumicell logo

Illumicell

illumicell.ai

Conceivable Life Sciences logo

Conceivable Life Sciences

conceivable.life

Claire logo

Claire

Sama Fertility logo

Sama Fertility

twoplus fertility logo

twoplus fertility

Microgenesis logo

Microgenesis

microgenesis.net

Pera Labs - Quick Facts

Who are Pera Labs' competitors?

Companies similar to Pera Labs include Hera Fertility, Pregmune, Lilia and Proov.

When was Pera Labs founded?

Pera Labs was founded in 2019.

Where is Pera Labs' headquarters located?

Pera Labs' headquarters is located in Philadelphia, PA, US.

How much has Pera Labs raised to-date?

As of Jun 5, 2023, Pera Labs has raised a total of $1.3M (USD).

How many employees does Pera Labs have?

Pera Labs has 12 employees as of Feb 4, 2024.

Pera Labs - Classification

Ownership
  • Venture Capital
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Consumers
Main Product
  • Fertility Solutions
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software